Geschäft · 17.7.20201 Min. Lesezeit
Eli Lilly and Co.; Announcement of the Revocation of the Biologics License for LARTRUVO
Lokale automatische Übersetzung · Originalsprache der Quelle
Zusammenfassung
The Food and Drug Administration (FDA or Agency) is announcing the revocation of the biologics license application (BLA) for LARTRUVO (olaratumab) injection. Eli Lilly and Co. requested withdrawal (revocation) of the biologics license application and has waived its opportunity for a hearing.